Furthermore, we previously reported that PEDF was significantly lower in acute coronary syndrome (ACS) patients than in controls, and lower PEDF levels were further associated with adverse cardiac outcomes after ACS [35]. This evidence concerns the gene SERPINF1 and acute coronary syndrome.